View in EDS

Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.

Saved in:
Bibliographic Details
Title: Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.
Authors: Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Anand IS; VA Medical Center and University of Minnesota, Minneapolis, Minnesota., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Lefkowitz MP; Novartis, East Hanover, New Jersey, USA., Maggioni AP; ANMCO Research Center, Florence, Italy., Martinez FA; University of Cordoba, Cordoba, Argentina., Redfield MM; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Quebec, Canada., Van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zannad F; Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, University Hospital, University of Lorraine, Nancy, France., Zile MR; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Source: JACC. Heart failure [JACC Heart Fail] 2025 Jun; Vol. 13 (6), pp. 927-939. Date of Electronic Publication: 2025 Mar 12.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40088233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kondo+T%22">Kondo T</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Jhund+PS%22">Jhund PS</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Anand+IS%22">Anand IS</searchLink>; VA Medical Center and University of Minnesota, Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Claggett+BL%22">Claggett BL</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Desai+AS%22">Desai AS</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Docherty+KF%22">Docherty KF</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lam+CSP%22">Lam CSP</searchLink>; National Heart Centre Singapore and Duke-National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lefkowitz+MP%22">Lefkowitz MP</searchLink>; Novartis, East Hanover, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Maggioni+AP%22">Maggioni AP</searchLink>; ANMCO Research Center, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Martinez+FA%22">Martinez FA</searchLink>; University of Cordoba, Cordoba, Argentina.<br /><searchLink fieldCode="AU" term="%22Redfield+MM%22">Redfield MM</searchLink>; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Rouleau+JL%22">Rouleau JL</searchLink>; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Van+Veldhuisen+DJ%22">Van Veldhuisen DJ</searchLink>; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zannad+F%22">Zannad F</searchLink>; Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists, University Hospital, University of Lorraine, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Zile+MR%22">Zile MR</searchLink>; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Packer+M%22">Packer M</searchLink>; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Solomon+SD%22">Solomon SD</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22McMurray+JJV%22">McMurray JJV</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101598241%22">JACC. Heart failure</searchLink> [JACC Heart Fail] 2025 Jun; Vol. 13 (6), pp. 927-939. <i>Date of Electronic Publication: </i>2025 Mar 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101598241 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-1787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222131779%22">22131779 </searchLink><i>NLM ISO Abbreviation: </i>JACC Heart Fail <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40088233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jchf.2024.12.010
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 927
    Titles:
      – TitleFull: Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kondo T
      – PersonEntity:
          Name:
            NameFull: Jhund PS
      – PersonEntity:
          Name:
            NameFull: Anand IS
      – PersonEntity:
          Name:
            NameFull: Claggett BL
      – PersonEntity:
          Name:
            NameFull: Desai AS
      – PersonEntity:
          Name:
            NameFull: Docherty KF
      – PersonEntity:
          Name:
            NameFull: Lam CSP
      – PersonEntity:
          Name:
            NameFull: Lefkowitz MP
      – PersonEntity:
          Name:
            NameFull: Maggioni AP
      – PersonEntity:
          Name:
            NameFull: Martinez FA
      – PersonEntity:
          Name:
            NameFull: Redfield MM
      – PersonEntity:
          Name:
            NameFull: Rouleau JL
      – PersonEntity:
          Name:
            NameFull: Van Veldhuisen DJ
      – PersonEntity:
          Name:
            NameFull: Zannad F
      – PersonEntity:
          Name:
            NameFull: Zile MR
      – PersonEntity:
          Name:
            NameFull: Packer M
      – PersonEntity:
          Name:
            NameFull: Solomon SD
      – PersonEntity:
          Name:
            NameFull: McMurray JJV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2213-1787
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: JACC. Heart failure
              Type: main
ResultId 1